Removal Selectivity and Advanced Filtration Membranes across Pharmaceutical Wastewater Plants

Abstract

The rapid escalation of pharmaceutical residues in aquatic environments poses severe ecological and public health challenges worldwide. Conventional wastewater treatment plants frequently fail to eliminate these complex synthetic compounds, necessitating the deployment of advanced filtration membranes. While nanofiltration and reverse osmosis demonstrate remarkable removal selectivity for active pharmaceutical ingredients, their energy-intensive nature and material manufacturing processes generate substantial environmental burdens. This paper provides a comprehensive investigation linking the physical and chemical selectivity of advanced filtration membranes to their holistic environmental impacts through a rigorous lifecycle assessment framework. Drawing on empirical data from a pilot-scale pharmaceutical wastewater treatment plant, this study evaluates the operational efficacy and environmental footprint of thin-film composite polyamide membranes. The analysis spans the entire lifecycle, from membrane fabrication and system operation to end-of-life disposal, quantifying trade-offs between removal efficiency and global warming potential, resource depletion, and human toxicity. Findings reveal that while high-selectivity membranes achieve near-complete retention of recalcitrant pharmaceutical compounds, the associated energy demands during the operational phase dominate the overall lifecycle impact. The study proposes optimization strategies, including energy recovery devices and alternative low-fouling membrane materials, to reconcile the conflict between exceptional water purification standards and environmental sustainability. This research offers critical insights for environmental engineers, policymakers, and plant operators striving to implement sustainable advanced wastewater treatment paradigms.